| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Corvus Pharmaceuticals Inc (NASDAQ: CRVS)
CRVS Technical Analysis
5
| As on 9th Jun 2023 CRVS SHARE Price closed @ 3.58 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.31 & Strong Buy for SHORT-TERM with Stoploss of 2.01 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRVSSHARE Price
| Open | 4.15 | Change | Price | % |
| High | 4.19 | 1 Day | -0.28 | -7.25 |
| Low | 3.53 | 1 Week | 0.54 | 17.76 |
| Close | 3.58 | 1 Month | 2.44 | 214.04 |
| Volume | 1454100 | 1 Year | 0.91 | 34.08 |
| 52 Week High 3.50 | 52 Week Low 0.65 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CRVS Daily Charts |
CRVS Intraday Charts |
Whats New @ Bazaartrend |
CRVS Free Analysis |
|
|
CRVS Important Levels Intraday
| RESISTANCE | 4.85 |
| RESISTANCE | 4.44 |
| RESISTANCE | 4.19 |
| RESISTANCE | 3.94 |
| SUPPORT | 3.22 |
| SUPPORT | 2.97 |
| SUPPORT | 2.72 |
| SUPPORT | 2.31 |
CRVS Forecast April 2024
| 4th UP Forecast | 5.04 |
| 3rd UP Forecast | 4.57 |
| 2nd UP Forecast | 4.28 |
| 1st UP Forecast | 3.99 |
| 1st DOWN Forecast | 3.17 |
| 2nd DOWN Forecast | 2.88 |
| 3rd DOWN Forecast | 2.59 |
| 4th DOWN Forecast | 2.12 |
CRVS Weekly Forecast
| 4th UP Forecast | 4.52 |
| 3rd UP Forecast | 4.22 |
| 2nd UP Forecast | 4.03 |
| 1st UP Forecast | 3.85 |
| 1st DOWN Forecast | 3.31 |
| 2nd DOWN Forecast | 3.13 |
| 3rd DOWN Forecast | 2.94 |
| 4th DOWN Forecast | 2.64 |
CRVS Forecast2024
| 4th UP Forecast | 10.48 |
| 3rd UP Forecast | 8.27 |
| 2nd UP Forecast | 6.9 |
| 1st UP Forecast | 5.53 |
| 1st DOWN Forecast | 1.63 |
| 2nd DOWN Forecast | 0.26 |
| 3rd DOWN Forecast | -1.11 |
| 4th DOWN Forecast | -3.32 |
Corvus Pharmaceuticals Inc ( NASDAQ USA Symbol : CRVS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRVS Business Profile
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-006, an anti-CD73 monoclonal antibody, which is in Phase I/Ib clinical trial that inhibits the production of adenosine and activate various immune cells, as Phase III clinical trial of CPI-006 for COVID-19. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase Ib/II clinical trial for adenosine, an immune checkpoint. Its preclinical stage products include CPI-182, an antibody to block neutrophil function and migration, and myeloid derived suppressor cells; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines. The company was incorporated in 2014 and is based in Burlingame, California. Address: 863 Mitten Road, Burlingame, CA, United States, 94010
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service